At the forefront of oncologic imaging, my tenure at Champalimaud Foundation has been dedicated to refining radiomic signatures to revolutionize cancer diagnosis and treatment. The mission at Champalimaud, a beacon of biomedical research, aligns perfectly with my goal to harness the power of advanced medical imaging for better patient outcomes. Collaboratively, our team has made significant strides in promoting MRI biomarkers in oncology.Parallel to my work at Champalimaud, I lead machine learning imaging initiatives at The Royal Marsden NHS Foundation Trust, integrating artificial intelligence to enhance imaging interpretation. The dual roles have honed my expertise in applying AI to medical imaging, a skill underscored by multiple honors and certifications. Leveraging this, alongside my proficiency in radiomics and machine learning, we aspire to set new standards in cancer care.